Global Drug-Device Combination Products Market Report, History and Forecast 2016-2027

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $3,350	147 Pages	QYResearch Group	January, 2022	QYR16931625

Best Price Guarantee
Price	from $3,350
Length	147 Pages
Publisher	QYResearch Group
Published Date	January, 2022
SKU	QYR16931625

Global Drug-Device Combination Products Market Report, History and Forecast 2016-2027

Summary

Market Analysis and Insights: Global Drug-Device Combination Products Market
The research report studies the Drug-Device Combination Products market using different methodologies and analyses to provide accurate and in-depth information about the market. For a clearer understanding, it is divided into several parts to cover different aspects of the market. Each area is then elaborated to help the reader comprehend the growth potential of each region and its contribution to the global market. The researchers have used primary and secondary methodologies to collate the information in the report. They have also used the same data to generate the current market scenario. This report is aimed at guiding people towards an apprehensive, better, and clearer knowledge of the market.
The global Drug-Device Combination Products market size is projected to reach US$ 117202 million by 2027, from US$ 76220 million in 2020, at a CAGR of 6.24% during 2021-2027.
Global Drug-Device Combination Products Scope and Segment
The global Drug-Device Combination Products market is segmented by company, region (country), by Type, and By Application. Players, stakeholders, and other participants in the global Drug-Device Combination Products market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and By Application for the period 2016-2027.
By Company
GSK
Novo Nordisk
Eli Lilly
AstraZeneca
Sanofi
Boston Scientific
Abbott
Boehringer Ingelheim
Medtronic
Mylan
3M
Hisamitsu
Smith & Nephew
Molnlycke
Teleflex
BD
Lepu Medical
MicroPort
Terumo
B. Braun
Antares Pharma

Segment by Type
Drug-Coated Device
Prefilled Drug Delivery Systems
Nebulizer & Inhaler
Transdermal Delivery System
Other

Segment by Application
Hospital & Clinic
Retail Pharmacies
Other

By Region
North America
United States
Canada
Mexico

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia

Europe
Germany
France
U.K.
Italy
Russia

South America
Brazil

Middle East & Africa
Middle East
Africa

1 MARKET OVERVIEW OF DRUG-DEVICE COMBINATION PRODUCTS: 1.1 Drug-Device Combination Products Market Overview; 1.1.1 Drug-Device Combination Products Product Scope; 1.1.2 Drug-Device Combination Products Market Status and Outlook; 1.2 Drug-Device Combination Products Market Overview by Type; 1.2.1 Drug-Coated Device; 1.2.2 Prefilled Drug Delivery Systems; 1.2.3 Nebulizer & Inhaler; 1.2.4 Transdermal Delivery System; 1.3 Global Drug-Device Combination Products Market Size by Type; 1.3.1 Global Drug-Device Combination Products Market Size Overview by Type (2016-2027); 1.3.2 Global Drug-Device Combination Products Historic Market Size Review by Type (2016-2021); 1.3.3 Global Drug-Device Combination Products Forecasted Market Size by Type (2022-2027); 1.4 Key Regions Market Size Segment by Type; 1.4.1 North America Drug-Device Combination Products Revenue Breakdown by Type (2016-2021); 1.4.2 Europe Drug-Device Combination Products Revenue Breakdown by Type (2016-2021); 1.4.3 Asia-Pacific Drug-Device Combination Products Revenue Breakdown by Type (2016-2021); 1.4.4 South America Drug-Device Combination Products Revenue Breakdown by Type (2016-2021); 1.4.5 Middle East and Africa Drug-Device Combination Products Revenue Breakdown by Type (2016-2021)
2 DRUG-DEVICE COMBINATION PRODUCTS MARKET COMPETITION BY COMPANY: 2.1 Global Drug-Device Combination Products Market Size by Players (2019-2021); 2.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Drug-Device Combination Products as of 2020); 2.3 Founded Date of Key Drug-Device Combination Products Players; 2.4 Global Top Players Drug-Device Combination Products Headquarters and Area Served; 2.5 Key Players Drug-Device Combination Products Product Solution and Service; 2.6 Competitive Status; 2.6.1 Drug-Device Combination Products Market Concentration Rate; 2.6.2 Mergers & Acquisitions, Expansion Plans
3 DRUG-DEVICE COMBINATION PRODUCTS STATUS AND OUTLOOK BY REGION: 3.1 Global Drug-Device Combination Products Market Size Overview by Region 2016 VS 2021 VS 2027; 3.2 Global Drug-Device Combination Products Market Size by Region (2016-2027); 3.3 Global Drug-Device Combination Products Historic Market Size by Region (2016-2021); 3.4 Global Drug-Device Combination Products Market Size Forecast by Region (2022-2027)
4 DRUG-DEVICE COMBINATION PRODUCTS MARKET OVERVIEW BY APPLICATION: 4.1 Drug-Device Combination Products Market Segment by Application; 4.1.1 Hospital & Clinic; 4.1.2 Retail Pharmacies; 4.2 Global Drug-Device Combination Products Market Size by Application; 4.2.1 Global Drug-Device Combination Products Market Size Overview by Application (2016-2027); 4.2.2 Global Drug-Device Combination Products Historic Market Size by Application (2016-2021); 4.2.3 Global Drug-Device Combination Products Forecasted Market Size by Application (2022-2027); 4.3 Key Regions Market Size Segment by Application; 4.3.1 North America Drug-Device Combination Products Revenue Breakdown by Application (2016-2021); 4.3.2 Europe Drug-Device Combination Products Revenue Breakdown by Application (2016-2021); 4.3.3 Asia-Pacific Drug-Device Combination Products Revenue Breakdown by Application (2016-2021); 4.3.4 South America Drug-Device Combination Products Revenue Breakdown by Application (2016-2021); 4.3.5 Middle East and Africa Drug-Device Combination Products Revenue Breakdown by Application (2016-2021)
5 NORTH AMERICA: 5.1 North America Drug-Device Combination Products Market Size by Country (2016-2027); 5.2 United States; 5.3 Canada; 5.4 Mexico
6 EUROPE: 6.1 Europe Drug-Device Combination Products Market Size by Country (2016-2027); 6.2 Germany; 6.3 France; 6.4 U.K.; 6.5 Italy; 6.6 Russia; 6.7 Rest of Europe
7 ASIA-PACIFIC: 7.1 Asia-Pacific Drug-Device Combination Products Market Size by Region (2016-2027); 7.2 China; 7.3 Japan; 7.4 South Korea; 7.5 Southeast Asia; 7.6 India; 7.7 Australia; 7.8 Rest of Asia-Pacific
8 SOUTH AMERICA: 8.1 South America Drug-Device Combination Products Market Size by Country (2016-2027); 8.2 Brazil; 8.3 Rest of South America
9 MIDDLE EAST & AFRICA: 9.1 Middle East & Africa Drug-Device Combination Products Market Size by Country; 9.2 Middle East; 9.3 Africa
10 COMPANY PROFILES AND KEY FIGURES IN DRUG-DEVICE COMBINATION PRODUCTS BUSINESS: 10.1 GSK; 10.1.1 GSK Corporation Information; 10.1.2 GSK Introduction and Business Overview; 10.1.3 GSK Drug-Device Combination Products Revenue and Gross Margin (2019-2021); 10.1.4 GSK Drug-Device Combination Products Offered; 10.1.5 GSK Recent Development; 10.2 Novo Nordisk; 10.2.1 Novo Nordisk Corporation Information; 10.2.2 Novo Nordisk Introduction and Business Overview; 10.2.3 Novo Nordisk Drug-Device Combination Products Revenue and Gross Margin (2019-2021); 10.2.4 Novo Nordisk Drug-Device Combination Products Offered; 10.2.5 Novo Nordisk Recent Development; 10.3 Eli Lilly; 10.3.1 Eli Lilly Corporation Information; 10.3.2 Eli Lilly Introduction and Business Overview; 10.3.3 Eli Lilly Drug-Device Combination Products Revenue and Gross Margin (2019-2021); 10.3.4 Eli Lilly Drug-Device Combination Products Offered; 10.3.5 Eli Lilly Recent Development; 10.4 AstraZeneca; 10.4.1 AstraZeneca Corporation Information; 10.4.2 AstraZeneca Introduction and Business Overview; 10.4.3 AstraZeneca Drug-Device Combination Products Revenue and Gross Margin (2019-2021); 10.4.4 AstraZeneca Drug-Device Combination Products Offered; 10.4.5 AstraZeneca Recent Development; 10.5 Sanofi; 10.5.1 Sanofi Corporation Information; 10.5.2 Sanofi Introduction and Business Overview; 10.5.3 Sanofi Drug-Device Combination Products Revenue and Gross Margin (2019-2021); 10.5.4 Sanofi Drug-Device Combination Products Offered; 10.5.5 Sanofi Recent Development; 10.6 Boston Scientific; 10.6.1 Boston Scientific Corporation Information; 10.6.2 Boston Scientific Introduction and Business Overview; 10.6.3 Boston Scientific Drug-Device Combination Products Revenue and Gross Margin (2019-2021); 10.6.4 Boston Scientific Drug-Device Combination Products Offered; 10.6.5 Boston Scientific Recent Development; 10.7 Abbott; 10.7.1 Abbott Corporation Information; 10.7.2 Abbott Introduction and Business Overview; 10.7.3 Abbott Drug-Device Combination Products Revenue and Gross Margin (2019-2021); 10.7.4 Abbott Drug-Device Combination Products Offered; 10.8 Boehringer Ingelheim; 10.8.1 Boehringer Ingelheim Corporation Information; 10.8.2 Boehringer Ingelheim Introduction and Business Overview; 10.8.3 Boehringer Ingelheim Drug-Device Combination Products Revenue and Gross Margin (2019-2021); 10.8.4 Boehringer Ingelheim Drug-Device Combination Products Offered; 10.8.5 Boehringer Ingelheim Recent Development; 10.9 Medtronic; 10.9.1 Medtronic Corporation Information; 10.9.2 Medtronic Introduction and Business Overview; 10.9.3 Medtronic Drug-Device Combination Products Revenue and Gross Margin (2019-2021); 10.9.4 Medtronic Drug-Device Combination Products Offered; 10.9.5 Medtronic Recent Development; 10.10 Mylan; 10.10.1 Mylan Corporation Information; 10.10.2 Mylan Introduction and Business Overview; 10.10.3 Mylan Drug-Device Combination Products Revenue and Gross Margin (2019-2021); 10.10.4 Mylan Drug-Device Combination Products Offered; 10.10.5 Mylan Recent Development; 10.11 3M; 10.11.1 3M Corporation Information; 10.11.2 3M Introduction and Business Overview; 10.11.3 3M Drug-Device Combination Products Revenue and Gross Margin (2019-2021); 10.11.4 3M Drug-Device Combination Products Offered; 10.12 Hisamitsu; 10.12.1 Hisamitsu Corporation Information; 10.12.2 Hisamitsu Introduction and Business Overview; 10.12.3 Hisamitsu Drug-Device Combination Products Revenue and Gross Margin (2019-2021); 10.12.4 Hisamitsu Drug-Device Combination Products Offered; 10.13 Smith & Nephew; 10.13.1 Smith & Nephew Corporation Information; 10.13.2 Smith & Nephew Introduction and Business Overview; 10.13.3 Smith & Nephew Drug-Device Combination Products Revenue and Gross Margin (2019-2021); 10.13.4 Smith & Nephew Drug-Device Combination Products Offered; 10.13.5 Smith & Nephew Recent Development; 10.14 Molnlycke; 10.14.1 Molnlycke Corporation Information; 10.14.2 Molnlycke Introduction and Business Overview; 10.14.3 Molnlycke Drug-Device Combination Products Revenue and Gross Margin (2019-2021); 10.14.4 Molnlycke Drug-Device Combination Products Offered; 10.15 Teleflex; 10.15.1 Teleflex Corporation Information; 10.15.2 Teleflex Introduction and Business Overview; 10.15.3 Teleflex Drug-Device Combination Products Revenue and Gross Margin (2019-2021); 10.15.4 Teleflex Drug-Device Combination Products Offered; 10.15.5 Teleflex Recent Development; 10.16 BD; 10.16.1 BD Corporation Information; 10.16.2 BD Introduction and Business Overview; 10.16.3 BD Drug-Device Combination Products Revenue and Gross Margin (2019-2021); 10.16.4 BD Drug-Device Combination Products Offered; 10.17 Lepu Medical; 10.17.1 Lepu Medical Corporation Information; 10.17.2 Lepu Medical Introduction and Business Overview; 10.17.3 Lepu Medical Drug-Device Combination Products Revenue and Gross Margin (2019-2021); 10.17.4 Lepu Medical Drug-Device Combination Products Offered; 10.18 MicroPort; 10.18.1 MicroPort Corporation Information; 10.18.2 MicroPort Introduction and Business Overview; 10.18.3 MicroPort Drug-Device Combination Products Revenue and Gross Margin (2019-2021); 10.18.4 MicroPort Drug-Device Combination Products Offered; 10.19 Terumo; 10.19.1 Terumo Corporation Information; 10.19.2 Terumo Introduction and Business Overview; 10.19.3 Terumo Drug-Device Combination Products Revenue and Gross Margin (2019-2021); 10.19.4 Terumo Drug-Device Combination Products Offered; 10.20 B. Braun; 10.20.1 B. Braun Corporation Information; 10.20.2 B. Braun Introduction and Business Overview; 10.20.3 B. Braun Drug-Device Combination Products Revenue and Gross Margin (2019-2021); 10.20.4 B. Braun Drug-Device Combination Products Offered; 10.21 Antares Pharma; 10.21.1 Antares Pharma Corporation Information; 10.21.2 Antares Pharma Introduction and Business Overview; 10.21.3 Antares Pharma Drug-Device Combination Products Revenue and Gross Margin (2019-2021); 10.21.4 Antares Pharma Drug-Device Combination Products Offered
11 UPSTREAM, OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS: 11.1 Drug-Device Combination Products Key Raw Materials; 11.1.1 Key Raw Materials; 11.1.2 Key Raw Materials Market Concentration Rate; 11.1.3 Raw Materials Key Suppliers; 11.2 Manufacturing Cost Structure; 11.2.1 Raw Materials; 11.2.2 Labor Cost; 11.2.3 Manufacturing Expenses; 11.3 Drug-Device Combination Products Industrial Chain Analysis; 11.4 Drug-Device Combination Products Market Dynamics; 11.4.1 Drug-Device Combination Products Industry Trends; 11.4.2 Drug-Device Combination Products Market Drivers; 11.4.3 Drug-Device Combination Products Market Challenges; 11.4.4 Drug-Device Combination Products Market Restraints
12 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS: 12.1 Sales Channel; 12.2 Drug-Device Combination Products Distributors; 12.3 Drug-Device Combination Products Downstream Customers
13 RESEARCH FINDING/CONCLUSION
14 METHODOLOGY AND DATA SOURCE: 14.1 Methodology/Research Approach; 14.1.1 Research Programs/Design; 14.1.2 Market Size Estimation; 14.1.3 Market Breakdown and Data Triangulation; 14.2 Data Source; 14.2.1 Secondary Sources; 14.2.2 Primary Sources; 14.3 Disclaimer; 14.4 Author List
List of Tables: Table 1. Major Company of Drug-Coated Device; Table 2. Major Company of Prefilled Drug Delivery Systems; Table 3. Major Company of Nebulizer & Inhaler; Table 4. Major Company of Transdermal Delivery System; Table 5. Global Drug-Device Combination Products Revenue by Type: 2016 VS 2021 VS 2027 (US$ Million); Table 6. Global Drug-Device Combination Products Revenue by Type (2016-2021) & (US$ Million); Table 7. Global Drug-Device Combination Products Revenue Market Share by Type (2016-2021); Table 8. Global Drug-Device Combination Products Revenue by Type (2022-2027) & (US$ Million); Table 9. Global Drug-Device Combination Products Revenue Market Share by Type (2022-2027); Table 10. North America Drug-Device Combination Products Revenue by Type (2016-2021) & (US$ Million); Table 11. Europe Drug-Device Combination Products Revenue by Type (2016-2021) & (US$ Million); Table 12. Asia-Pacific Drug-Device Combination Products Revenue by Type (2016-2021) & (US$ Million); Table 13. South America Drug-Device Combination Products Revenue by Type (2016-2021) & (US$ Million); Table 14. Middle East and Africa Drug-Device Combination Products Revenue by Type (2016-2021) & (US$ Million); Table 15. Global Drug-Device Combination Products Revenue (US$ Million) by Players (2019-2021); Table 16. Global Drug-Device Combination Products Revenue Market Share by Players (2019-2021); Table 17. Global Top Players Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug-Device Combination Products as of 2020); Table 18. Founded Date of Key Drug-Device Combination Products Players; Table 19. Global Drug-Device Combination Products Top Players Headquarters and Area Served; Table 20. Drug-Device Combination Products Product Solution and Service; Table 21. Global Drug-Device Combination Products Players Market Concentration Ratio (CR5 and HHI); Table 22. Mergers & Acquisitions, Expansion Plans; Table 23. Global Market Drug-Device Combination Products Market Size (US$ Million) Comparison by Region: 2016 VS 2021 VS 2027; Table 24. Global Drug-Device Combination Products Market Size by Region (2016-2021) & (US$ Million); Table 25. Global Drug-Device Combination Products Market Size Share by Region (2016-2021); Table 26. Global Drug-Device Combination Products Forecasted Market Size by Region (2022-2027) & (US$ Million); Table 27. Global Drug-Device Combination Products Forecasted Market Size Share by Region (2022-2027); Table 28. Global Drug-Device Combination Products Market Size (US$ Million) By Application: 2016 VS 2021 VS 2027; Table 29. Global Drug-Device Combination Products Market Size by Application (2016-2021) & (US$ Million); Table 30. Global Drug-Device Combination Products Revenue Market Share by Application (2016-2021); Table 31. Global Drug-Device Combination Products Forecasted Market Size by Application (2022-2027) & (US$ Million); Table 32. Global Drug-Device Combination Products Revenue Market Share by Application (2022-2027); Table 33. North America Drug-Device Combination Products Revenue by Application (2016-2021) & (US$ Million); Table 34. Europe Drug-Device Combination Products Revenue by Application (2016-2021) & (US$ Million); Table 35. Asia-Pacific Drug-Device Combination Products Revenue by Application (2016-2021) & (US$ Million); Table 36. South America Drug-Device Combination Products Revenue by Application (2016-2021) & (US$ Million); Table 37. South America Drug-Device Combination Products Revenue Market Share by Application (2016-2021); Table 38. Middle East and Africa Drug-Device Combination Products Revenue by Application (2016-2021) & (US$ Million); Table 39. North America Drug-Device Combination Products Market Size by Country (2016-2021) & (US$ Million); Table 40. North America Drug-Device Combination Products Market Size by Country (2022-2027) & (US$ Million); Table 41. Europe Drug-Device Combination Products Market Size by Country (2016-2021) & (US$ Million); Table 42. Europe Drug-Device Combination Products Market Size by Country (2022-2027) & (US$ Million); Table 43. Europe Drug-Device Combination Products Market Share by Country (2016-2021); Table 44. Europe Drug-Device Combination Products Market Share by Country (2022-2027); Table 45. Asia-Pacific Drug-Device Combination Products Market Size by Region (2016-2021) & (US$ Million); Table 46. Asia-Pacific Drug-Device Combination Products Market Size by Region (2022-2027) & (US$ Million)